Silicon Therapeutics

Provider of In-Silico Targeted Engineering platform to build in silico models of human drug targets

placeBoston, Massachusetts, United States calendar_todayFounded 2016 groups61 employees language silicontx.com

Registered entities

Investor mix

1 investor on record; lead investors include Chengwei Capital.

Investor typeCountShare
Venture capital1100%
Coming soon